[TF-KY] Subsidiary Taiwan TF Biotech Announces Capital Reduction to Offset Losses and Creditor Notification
Key facts
- [TF-KY] Subsidiary Taiwan TF Biotech Announces Capital Reduction to Offset Losses and Creditor Notification
- Taiwan TF Biotech has resolved to carry out a 99.4% capital reduction to improve its financial structure. The reduction amount is NT$2.496 billion, with the decision made by the board due to a single-shareholder structure.
- Source: PR Times
- Date: June 22, 2026
Direct answer
Taiwan TF Biotech has resolved to carry out a 99.4% capital reduction to improve its financial structure. The reduction amount is NT$2.496 billion, with the decision made by the board due to a single-shareholder structure.
- Citation
- [TF-KY] Subsidiary Taiwan TF Biotech Announces Capital Reduction to Offset Losses and Creditor Notification (June 22, 2026), PR Times
- Source
- PR Times
- Date
- June 22, 2026
Taiwan TF Biotech has resolved to carry out a 99.4% capital reduction to improve its financial structure. The reduction amount is NT$2.496 billion, with the decision made by the board due to a single-shareholder structure.
📋 Article Processing Timeline
- 📰 Published: June 22, 2026 at 09:00
- 🔍 Collected: June 23, 2026 at 17:00 (32h 0m after Published)
- 🤖 AI Analyzed: June 23, 2026 at 17:04 (4 min after Collected)
1. Board resolution date: 115/06/22
2. Reason for capital reduction: In accordance with group operational planning and to improve financial structure
3. Amount of capital reduction: NT$2,495,707,000
4. Number of shares to be eliminated: 249,570,700 shares
5. Capital reduction ratio: 99.40255872%
6. Capital after reduction: NT$15,000,000
7. Scheduled shareholders' meeting date: Not applicable
8. Expected number of listed common shares after new shares from capital reduction are listed: Not applicable
9. Ratio of listed common shares to total issued common shares after capital reduction (listed common shares / total issued common shares): Not applicable
10. If the number of listed common shares after capital reduction is less than 60 million shares and less than 25%, explanation of measures for low share liquidity: Not applicable
11. Capital reduction reference date: 115/06/22
12. Other matters to be disclosed:
(1) The company has a single legal shareholder and a single director; therefore, the chairman exercises the authority of the shareholders' meeting.
(2) In accordance with Article 73 and Article 74 as applied by Article 281 of the Company Act, the company hereby announces the capital reduction to its creditors. Creditors who have objections to this resolution must submit written objections with supporting documentation within 31 days from the announcement date (mailing address for written objections: 3F, No. 22, Shengyi 2nd Road, Zhubei City, Hsinchu County, Taiwan). The company will proceed in accordance with legal procedures. Creditors who do not express objections within the time limit will be deemed to have no objections.
2. Reason for capital reduction: In accordance with group operational planning and to improve financial structure
3. Amount of capital reduction: NT$2,495,707,000
4. Number of shares to be eliminated: 249,570,700 shares
5. Capital reduction ratio: 99.40255872%
6. Capital after reduction: NT$15,000,000
7. Scheduled shareholders' meeting date: Not applicable
8. Expected number of listed common shares after new shares from capital reduction are listed: Not applicable
9. Ratio of listed common shares to total issued common shares after capital reduction (listed common shares / total issued common shares): Not applicable
10. If the number of listed common shares after capital reduction is less than 60 million shares and less than 25%, explanation of measures for low share liquidity: Not applicable
11. Capital reduction reference date: 115/06/22
12. Other matters to be disclosed:
(1) The company has a single legal shareholder and a single director; therefore, the chairman exercises the authority of the shareholders' meeting.
(2) In accordance with Article 73 and Article 74 as applied by Article 281 of the Company Act, the company hereby announces the capital reduction to its creditors. Creditors who have objections to this resolution must submit written objections with supporting documentation within 31 days from the announcement date (mailing address for written objections: 3F, No. 22, Shengyi 2nd Road, Zhubei City, Hsinchu County, Taiwan). The company will proceed in accordance with legal procedures. Creditors who do not express objections within the time limit will be deemed to have no objections.
FAQ
What is the capital reduction ratio of Taiwan TF Biotech?
The reduction ratio is 99.40255872%, nearly a full capital cut.
Why is the company reducing capital?
To improve financial structure in line with group operational planning.
What will be the paid-in capital after reduction?
It will be reduced to NT$15 million.
What should creditors do?
Creditors must submit written objections within 31 days of the announcement.
Who made this resolution?
The chairman exercised shareholder authority due to single legal shareholder structure.